Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems
Background: Schistosomiasis is a water-borne disease afflicting over 261 million people in many areas of the developing countries with high morbidity and mortality. The control relies mainly on treatment with praziquantel. Fatty acid binding proteins (FABP) have demonstrated high levels of immune-pr...
- Autores:
-
Vicente B.
López-Abán J.
Rojas Caraballo, Jose vicente
Del Olmo E.
Fernández-Soto P.
Muro A.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2023
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/49573
- Acceso en línea:
- https://doi.org/10.1186/s13071-016-1500-y
https://www.scopus.com/inward/record.uri?eid=2-s2.0-84963877246&doi=10.1186%2fs13071-016-1500-y&partnerID=40&md5=d1227d83c9f812ed9a9271b578a613e2
https://hdl.handle.net/20.500.12494/49573
- Palabra clave:
- ANIMAL
ANIMAL EXPERIMENT
ANIMAL MODEL
ANIMAL TISSUE
ANIMALS
ANTIBODIES, HELMINTH
ANTIBODY RESPONSE
ARTICLE
BACULOVIRIDAE
BAGG ALBINO MOUSE
CERCARIA
CONTROLLED STUDY
CROSS PROTECTION
CYTOKINE PRODUCTION
DRUG DELIVERY SYSTEM
DRUG DELIVERY SYSTEMS
ESCHERICHIA COLI
FASCIOLA HEPATICA
FATTY ACID BINDING PROTEIN
FATTY ACID-BINDING PROTEINS
FEMALE
GAMMA INTERFERON
GENETICS
H
HELMINTH ANTIBODY
HELMINTH PROTEIN
HELMINTH PROTEINS
HUMAN
IMMUNOGLOBULIN E ANTIBODY
IMMUNOGLOBULIN G ANTIBODY
IMMUNOGLOBULIN G1 ANTIBODY
IMMUNOGLOBULIN G2A ANTIBODY
IMMUNOGLOBULIN M ANTIBODY
IMMUNOLOGY
IMMUNOMODULATING AGENT
INTERLEUKIN 2
INTERLEUKIN 4
INTERLEUKIN 6
INTESTINE
MOUSE
NONHUMAN
PARASITE LOAD
PARASITOLOGY
RECOMBINANT PROTEIN
SCHISTOSOMA VACCINE
SCHISTOSOMIASIS MANSONI
SPLEEN CELL
TUMOR NECROSIS FACTOR ALPHA
VACCINATION
- Rights
- openAccess
- License
- http://purl.org/coar/access_right/c_abf2